RecruitingNot ApplicableNCT07220239

Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome

Menstrual Cup-based Endometrial Collection as an Alternative to Endometrial Biopsy in Lynch Syndrome Patients


Sponsor

Jessica D. St. Laurent, MD

Enrollment

25 participants

Start Date

Nov 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Study Goal: This pilot study wants to find out if using a menstrual cup can be a good, non-invasive way to collect samples from the lining of the uterus (called the endometrium) to help screen for endometrial cancer. This is especially important for women who have a higher chance of getting this cancer, such as those with a genetic condition called Lynch syndrome. Main Questions the Study Will Answer: 1. Can a menstrual cup collect enough uterine lining (endometrial tissue) for doctors to examine under a microscope? 2. Are the samples from the menstrual cup as useful for diagnosis as samples taken using the usual method (called an endometrial biopsy or EMB)? 3. Is using a menstrual cup at home easy, effective, and comfortable for participants? 4. Can scientists grow small lab models of the uterus (called organoids) from the menstrual cup samples and from biopsy samples? What Will Happen in the Study: * Participants will use a menstrual cup at home to collect menstrual blood. * They will also have a standard endometrial biopsy done by a healthcare provider. * After both collections, participants will fill out a short survey about how comfortable and easy it was to use the menstrual cup. What the Study Will Measure: * Feasibility: How well participants are able to use the menstrual cup and send in the sample. * Sample Quality: Whether the menstrual cup collects enough good-quality tissue for testing, and how it compares to biopsy samples. * Participant Experience: How women feel about using the menstrual cup, based on the survey. * Lab Testing: Whether researchers can successfully grow endometrial organoids from both types of samples. Why This Study Matters: If this method works, it could offer a gentler, more convenient way for women to get checked for endometrial cancer-especially those who need regular screening. It could also make it easier to collect samples for research and improve early detection of cancer.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring whether menstrual cups can be used to collect cells from the uterus to detect early signs of uterine (endometrial) cancer. It is focused on people with Lynch syndrome — a hereditary condition that raises the risk of several cancers including uterine cancer. The goal is to develop a less invasive alternative to current screening procedures. **You may be eligible if...** - You are 18 or older and currently menstruating - For the main study: You have Lynch syndrome (a confirmed genetic mutation in MLH1, MSH2, MSH6, PMS2, or EPCAM) - You are scheduled for a routine uterine biopsy (endometrial biopsy) as part of standard care **You may NOT be eligible if...** - You currently have or recently removed a hormonal IUD (within 30 days) - You have had a prior endometrial ablation procedure - You have a history of uterine cancer or pre-cancer - You are allergic to silicone (the material in menstrual cups) - You are currently pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMenstrual cup use

Menstrual cup use in menstruating women to collect menstrual fluid with the aim to 1) compare the histology to endometrial biopsy samples from the same patient, to 2) investigate the feasibility and clinical utility of a menstrual cup use as a screening method for endometrial cancer and to 3) generate organoids from the menstrual cup samples


Locations(1)

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07220239


Related Trials